• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    Agenus Inc. (AGEN)

    -NasdaqCM
    8.18 Up 0.56(7.35%) May 29, 4:00PM EDT
    |After Hours : 8.05 Down 0.13 (1.59%) May 29, 7:59PM EDT
    Add to Portfolio
    Prev Close:7.62
    Open:7.61
    Bid:8.01 x 2000
    Ask:8.45 x 100
    1y Target Est:10.00
    Beta:0.16
    Earnings Date:Jul 22 - Jul 27 (Est.)
    Day's Range:7.55 - 8.25
    52wk Range:2.56 - 8.25
    Volume:2,462,556
    Avg Vol (3m):1,453,540
    Market Cap:584.75M
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AGEN

    Comparison

    Symbol% ChgMkt Cap
    AGENUp 7.35%584.75M
    ABPIDown 4.26%N/A
    DNDN 0.00%20.16M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):53.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.78
    Quarterly EPS Est (Jun-15) :-0.18
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback